Menu

Impax Laboratories, Inc. IPXL

Full chart Compare
Set alert

Price alert · IPXL

All alert types
18.30 0.00 (+0.00%)

At closeJun 28, 2019, 6:07 PM EDT

17.40 Day range 18.95

52-week range unavailable

Revenue & Expenses

Revenue by
Impax Generics → Revenue: $549.08MRevenue → Gross Profit: $240.66MGross Profit → Expenses: $240.66MRevenue → Cost of Revenue: $535.12MExpenses → Selling, General & Admin: $216.27MExpenses → Research & Development: $80.85MExpenses → Other Operating Expenses: $249.37MExpenses → Other Expenses: $145.13MExpenses → Income Tax: $18.33MNet Loss → Expenses: $469.29MImpax Specialty Pharma → Revenue: $226.71MGross Profit$240.66MNet Loss$469.29MCost of Revenue$535.12MExpenses$709.95MSelling, General & Admin$216.27MResearch & Development$80.85MOther Operating Expenses$249.37MOther Expenses$145.13MIncome Tax$18.33MRevenue$775.79MImpax Generics$549.08MImpax Specialty Pharma$226.71M

Latest period ending Dec 31, 2017 · select a line to chart its full history

IPXL annual income statement
Fiscal yearFY 2017 Dec 31, 2017FY 2016 Dec 31, 2016FY 2015 Dec 31, 2015FY 2014 Dec 31, 2014FY 2013 Dec 31, 2013
775.79M824.43M860.47M596.05M511.50M
143.80M-151.10M352.40M312.65M199.30M
-433.74M-494.18M69.57M88.82M-6.39M
-469.29M-472.03M39.00M57.35M101.26M
-6.53-6.630.540.811.47
IPXL annual balance sheet
Fiscal yearFY 2017 Dec 31, 2017FY 2016 Dec 31, 2016FY 2015 Dec 31, 2015FY 2014 Dec 31, 2014FY 2013 Dec 31, 2013
181.78M180.13M340.35M214.87M184.61M
1.35B1.82B1.92B1.08B996.92M
1.16B1.20B860.08M191.32M186.72M
787.37M831.26M424.60M00
187.20M623.97M1.06B887.88M810.20M
IPXL annual cash flow
Fiscal yearFY 2017 Dec 31, 2017FY 2016 Dec 31, 2016FY 2015 Dec 31, 2015FY 2014 Dec 31, 2014FY 2013 Dec 31, 2013
84.22M83.85M92.45M32.82M149.94M
-9.68M-627.09M-467.54M-16.60M-115.89M
-73.67M382.53M500.86M14.41M8.96M
-17.64M-48.04M-25.20M-29.91M-32.78M
1.65M-160.22M125.48M30.26M42.45M